Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza vaccine and is taken into UN purchase plan.

Flu is one of the most severe epidemic diseases human encountered, as well as the infectious disease causing the maximal death toll.

WHO Pre-qualification is one UN action plan, launched in 2001 and aimed at expanding the acquisition of selected prior drug and ensuring the quality, efficacy and safety of purchasing drug in international fund (such as the global fund GFTAM and UN aid international drug purchase mechanism UNITAID).

Hualan Bio has the capacity to produce influenza vaccine of three dosage forms for more than 50 million human doses and single dosage form for 300 million human doses annually.